Vanguard Group’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
|
|||||
|
2025
Q1 | $6.46M | Buy |
|
|||||
|
2024
Q4 | $3.45M | Buy |
|
|||||
|
2024
Q3 | $3.88M | Buy |
|
|||||
|
2024
Q2 | $5.54M | Buy |
|
|||||
|
2024
Q1 | $6.36M | Hold |
|
|||||
|
2023
Q4 | $6.1M | Sell |
|
|||||
|
2023
Q3 | $3.73M | Hold |
|
|||||
|
2023
Q2 | $5M | Buy |
|
|||||
|
2023
Q1 | $3.5M | Hold |
|
|||||
|
2022
Q4 | $3.43M | Buy |
|
|||||
|
2022
Q3 | $3.36M | Sell |
|
|||||
|
2022
Q2 | $4.89M | Hold |
|
|||||
|
2022
Q1 | $4.66M | Buy |
|
|||||
|
2021
Q4 | $5.21M | Buy |
|
|||||
|
2021
Q3 | $8.72M | Buy |
|
|||||
|
2021
Q2 | $6.66M | Buy |
|
|||||
|
2021
Q1 | $3.72M | Buy |
|
|||||
|
2020
Q4 | $4.36M | Buy |
|
|||||
|
2020
Q3 | $2.13M | Buy |
|